Integrated Imaging Technology Aims To Provide Real-Time Look at Cancer Treatment
TROY, N.Y. — If researchers could observe drug delivery and its effect on cancer cells in real time, they would be able to tailor treatment options with unprecedented specificity. An academic-industrial partnership between engineers at Rensselaer Polytechnic Institute, molecular and cellular biologists at Albany Medical College, and engineers at MARS Bioimaging Ltd aims to make this a reality for the treatment of breast cancer through the combination of highly innovative X-ray and optical imaging technologies.